October 20, 2016
Painful sex in women after cancer treatment is relatively common, often treatable and needs to be addressed by medical providers, a UC Davis oncologist and researcher suggests.
October 18, 2016
Young adults dealing with the effects of cancer are invited to attend Pushing Past Cancer, a free day of education and motivation, on Saturday, Nov. 5, from 9:30 a.m. to 5 p.m. at the UC Davis Sacramento campus. The event is open to cancer patients ages 18-40, their support persons and medical professionals.
October 13, 2016
The National Institutes of Health (NIH) has named the California Precision Medicine Consortium as a regional medical center group in the national network of health care provider organizations that will implement the Precision Medicine Initiative (PMI) Cohort Program.
October 4, 2016
More than 80 people attended the 4th annual Cancer Care Network Symposium Saturday at the UC Davis Comprehensive Cancer Center auditorium to explore key topics in cancer care, including the new End of Life Option Act.
September 23, 2016
Kit Lam, professor and chair of the UC Davis Department of Biochemistry and Molecular Medicine, has received two major cancer research grants totaling more than $3 million.
September 20, 2016
Kit Lam, professor and chair of the UC Davis Department of Biochemistry and Molecular Medicine, has been appointed to the National Cancer Institute’s Basic Science Board of Scientific Counselors (BSC).
September 9, 2016
Training oncologists and their patients to have high-quality discussions improves communication, but troubling gaps still exist between the two groups, according to a new study in JAMA Oncology.
September 8, 2016
Marking Ovarian Cancer Awareness Month and the need for more research and education about the disease, Let’s ROC, the annual 5K run is set for Sunday, Sept. 18 at 8 a.m.
September 7, 2016
The cancer center's pharmacist-driven oral anti-cancer medication adherence program, led by Iris C. Zhao, has earned the 2016 California Society of Health System Pharmacist’s (CSHP) Innovative Pharmacy Practice Award.
September 6, 2016
The National Cancer Institute has again funded the K12 Paul Calabresi Clinical Oncology Training Grant to promote and sustain the development of young cancer scientists from diverse fields and from laboratories and clinics across both UC Davis campuses.
August 31, 2016
A new report from the UC Davis Institute for Population Health Improvement (IPHI) shows the impact of cancer screening over the past 15 years, identifying areas where increased screening and other cancer-control efforts would save lives and significantly benefit population health.
August 26, 2016
Hmong Americans are more likely to understand the importance of colorectal cancer screening and to get screened when they’re provided information by specially trained Hmong lay health educators, new research from UC Davis has found.
August 22, 2016
Becker’s Hospital Review has named UC Davis Health System one of 100 in the country with “great oncology programs.”
August 5, 2016
The Prostate Cancer Foundation and Movember, the global charity that has raised hundreds of millions for men’s health research and programs, have delivered $1 million to UC Davis prostate cancer researchers.
July 28, 2016
Researchers at UC Davis and Ionis Pharmaceuticals have developed a hybrid treatment that harnesses a monoclonal antibody to deliver antisense DNA to acute lymphoblastic leukemia (ALL) cells and that may lead to less toxic treatments for the disease.
July 26, 2016
Ralph de Vere White, who retired in June as director of the UC Davis Comprehensive Cancer Center, has been named to a key committee at the National Institute of Health (NIH).
July 21, 2016
The play area in the pediatric infusion center is buzzing with activity. Kids are building, coloring, reading and, most importantly, laughing. Not just patients, but parents and siblings, too. The play area isn’t just a haphazard jumble of donated toys and books, it’s a space specially designed by the cancer center’s resident child life specialist and expert on fun, Ellen Meuchel.
July 14, 2016
Patients with stage III or IV cancer report far more optimistic expectations for survival than their oncologists thought they had communicated, according to new research published today in JAMA Oncology. Effective communication between doctors and their patients who could be nearing the end of their lives is crucial, according to the authors, since this is when quality-of-life decisions merge with discussions about treatment options.
July 14, 2016
Lily Chiquet would have been 4 this week.
June 29, 2016
Ralph de Vere White, who steps down this week after a 32-year career at UC Davis Health System, has been honored with an educational endowment in his name.
June 7, 2016
Patients with late-stage, non-small cell lung cancer (NSCLC) who have surgery have better survival rates than those who don’t, but fewer of these patients are undergoing surgery, UC Davis researchers have found.
May 31, 2016
Ralph de Vere White, a beloved urologist and acclaimed researcher who led the UC Davis Comprehensive Cancer to designation by the National Cancer Institute (NCI), steps down as its long-time director on June 29.
May 25, 2016
Diana Miglioretti, UC Davis dean’s professor of biostatistics and an internationally recognized breast cancer screening expert, has received $7.5 million to determine the effectiveness of two supplemental breast screening and diagnostic workup strategies -- digital breast tomosynthesis (3D mammography) and magnetic resonance imaging (MRI) -- used with mammography for cancer detection. Miglioretti’s team also will work to determine whether effectiveness of the screening strategies depends on a woman’s breast density.
May 17, 2016
The National Cancer Institute (NCI) has re-designated the UC Davis Comprehensive Cancer Center “comprehensive,” meaning that it meets stringent criteria in the areas of laboratory, clinical and population-based research, professional and public education and in the dissemination of clinical and public advances to the communities it serves.
May 3, 2016
Autism and cancer share more than 40 risk genes, suggesting that common mechanisms underlying the functions of some of these genes could conceivably be leveraged to develop therapies not just for cancer but for autism as well, an extensive assessment by researchers with the UC Davis MIND Institute and Comprehensive Cancer Center has found.
May 2, 2016
Researchers at UC Davis have shown that docosahexaenoic acid (DHA), a fatty acid commonly found in fish and fish oil supplements, reduces renal cell carcinoma invasiveness, growth rate, and blood vessel growth when combined with the anti-cancer therapy regorafenib. The study was published in the May issue of the journal Molecular Cancer Therapeutics.
May 2, 2016
A community-based hepatitis B virus screening effort led by UC Davis researchers found that targeted outreach to Asian American populations can identify groups at high risk for infection and direct them to appropriate follow-up care to help prevent the onset of liver diseases, including cancer.
April 26, 2016
UC Davis molecular biologist John Albeck is among 10 recipients chosen to receive a 2016 Innovative Research Grant (IRG) from Stand Up to Cancer (SU2C), a non-profit that supports innovative, high-risk, high-reward projects to accelerate the pace of cancer research and give patients access to new therapies as quickly as possible.
April 20, 2016
The UC Davis Comprehensive Cancer Center’s Division of Hematology/Oncology has been recognized by the Quality Oncology Practice Initiative (QOPI) Certification Program for meeting the nation’s highest quality standards for cancer care.
April 20, 2016
Linda Farkas, a surgeon and expert in hereditary cancers, has joined UC Davis Health System as a professor of surgery and chief of the newly created Division of Colon and Rectal Surgery.
April 17, 2016
The International Cancer Genome Consortium (ICGC) today announced plans to launch of the International Cancer Genome Consortium for Medicine (ICGCmed), a new phase in the consortium’s evolution that will link genomics to clinical information and health.
April 11, 2016
UC Davis researchers have shown that radiation therapy following surgery benefits older patients more than their younger counterparts, a surprising finding that could change the way some patients are treated for soft tissue sarcomas (STS).
March 28, 2016
Researchers at UC Davis, in collaboration with the other institutions, have found that suppressing the nuclear receptor protein ROR-γ with small-molecule compounds can reduce androgen receptor (AR) levels in castration-resistant prostate cancer and stop tumor growth.
March 21, 2016
Two new UC Davis research efforts, one aimed at addressing fatal early childhood conditions known as Tay-Sachs and Sandhoff disease, the other designed to develop an immunotherapy that would eradicate solid tumor cancer stem cells and create sustained anti-tumor effects, have been approved for funding by the California Institute for Regenerative Medicine (CIRM).
February 24, 2016
Two UC Davis Children’s Hospital and UC Davis Comprehensive Cancer Center patients had the chance to forget about cancer treatments for an evening and meet Princess Anna and Princess Elsa from Frozen at recent Disney On Ice performances.
February 24, 2016
Sandy Gantt receives infusions of chemotherapy to treat her leukemia for hours on end, day after day. But she’s found one thing that transports her from that reality to a less stressful place.
February 24, 2016
It can’t be easy parting with a head of beautiful long, dark hair. But that’s exactly what Venessa Garcia plans to do. A patient care coordinator at UC Davis Comprehensive Cancer Center, Garcia will undergo the razor treatment March 14 during the annual St. Baldrick’s Foundation event for pediatric cancer research.
February 1, 2016
Researchers at UC Davis and Lawrence Livermore and Los Alamos national laboratories have created a chemotherapy-resistant line of bladder cancer cells to study how tumors become resistant to chemotherapy and identified molecular changes that could drive that resistance.
January 29, 2016
African American and Hispanic adolescents and young adults fare far worse than their white counterparts when faced with a mostly curable type of cancer, Hodgkin lymphoma, a study by a UC Davis epidemiologist has found.
January 22, 2016
UC Davis physician and health policy expert Joy Melnikow has been appointed to the panel of the California Technology Assessment Forum of the Institute for Clinical and Economic Review.
January 11, 2016
A systematic review of the scientific literature on dense breasts by researchers at UC Davis and other institutions has found that determinations of breast density can be unreliable and that as many as 19 percent of women are re-categorized as dense rather than non-dense or vice versa from one mammogram to the next.
January 11, 2016
In a comprehensive modeling study, researchers from UC Davis and other institutions have found that breast cancer screening with digital mammography poses only a small risk of radiation-induced breast cancer for most women.
Women recognize UC Davis as one of America's best hospitals for bariatric surgery, cancer and heart care
January 8, 2016
UC Davis Medical Center has received the 2016 Women’s Choice Award as one of America’s best hospitals for bariatric surgery, cancer and heart care.
December 23, 2015
Buster Halcomb was just 5, a scruffy shoeshine boy in a billiard hall in Cumberland, Ky., when three men approached with packs of “tailor-made” cigarettes.
December 3, 2015
In a game-changing study, researchers at UC Davis and other organizations have shown that the enzyme cyclin-dependent kinase 1 (CDK1), which plays a key role in DNA repair, also leaves the nucleus to boost cellular energy production. By irradiating normal cells, the team showed that CDK1 turned up production of ATP, cellular energy packets that – in this case – provided the necessary power supply to fix the radiation-damaged DNA.
November 18, 2015
Kit Lam, professor and chair of the Department of Biochemistry and Molecular Medicine, has been awarded two major, multi-disciplinary U01 grants from the National Institutes of Health (NIH), the first to investigate use of a new tool to visualize cancer tumor growth and response to nanoparticle drugs, and the other to develop a new 4-D imaging tool to advance the understanding of how the nucleus functions in living cells.
November 17, 2015
Researchers at the UC Davis Comprehensive Cancer Center have shown that the microRNA, miR-124, reduced tumor growth and increased cell death in castration-resistant prostate cancer.
November 4, 2015
Karen Kelly, associate director for clinical research at the UC Davis Comprehensive Cancer Center, has been named chair of the Lung Committee of SWOG, one of the nation’s leading cooperative cancer research organizations.